Header links
Intranet
Donate now
image/svg+xml Map
Contact us

General finder

What are you looking for?

Write the name, title or any keyword related to what you are looking for and select which content category it belongs to.

Year
2024
Data d'inici
Data de tancament
Grup de recerca
Childhood Cancer and Blood Disorders
Descripció
Administrative and Financial Assistant_20240104
Codi
2024-104
URL Document vinculat
http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0104//2024_0104_001.pdf
Reclutant
Inactiu
Year
2024
Data d'inici
Data de tancament
Descripció
Clinical Research Quality Manager_20240105
Codi
2024-105
URL Document vinculat
http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0105//2024_0105_001.pdf
Reclutant
Inactiu

Professionals

Sabrina Ayelen Gatti

Professionals

Ajla Idrizovic

Professionals

Núria Pérez Picazo

 I have a degree in Pharmacy from University of Barcelona and I have a "Master in monitoring International Clinical Trials" and a "Postgraduate Degree in Pharmacovigilance". Since March 2014 I have been part of Academic Research Organization (ARO) of VHIR. Initially as CRA and since 2015 as Project

Professionals

Lidia Fuertes Rioja

Professionals

Anna Roig Pratdepadua

Professionals

Marta Pinsach Batet
Year
2024
Data d'inici
Data de tancament
Descripció
Pre-Award Research Officer_2024102
Codi
2024-102
URL Document vinculat
http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0102//2024_0102_001.pdf
Reclutant
Inactiu
Year
2024
Data d'inici
Data de tancament
Descripció
International Post-Award Research Manager
Codi
2024-99
URL Document vinculat
http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0099//2024_0099_001.pdf
Reclutant
Inactiu
Year
2024
Data d'inici
Data de tancament
Descripció
Bioinformatics Technician - UEB
Codi
2024-100
URL Document vinculat
http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0100//2024_0100_001.pdf
Reclutant
Inactiu
Year
2024
Data d'inici
Data de tancament
Descripció
Junior Innovation Manager_20240101
Codi
2024-101
URL Document vinculat
http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0101//2024_0101_001.pdf
Reclutant
Inactiu
Year
2024
Data d'inici
Data de tancament
Grup de recerca
Shock, Organ Dysfunction and Resuscitation
Descripció
Data Science-Intensive Care Unit/ Shock, Organ Dysfunction and Resuscitation Group_20240095
Codi
2024-95
URL Document vinculat
http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0095//2024_0095_001.pdf
Reclutant
Inactiu
Year
2024
Data d'inici
Data de tancament
Grup de recerca
Maternal and Fetal Medicine
Descripció
Auxiliary Nursing Care Technician (TCAE) Assisted reproduction and gynecological endocrinology Unit_20240096
Codi
2024-96
URL Document vinculat
http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0096//2024_0096_001.pdf
Reclutant
Inactiu
Year
2024
Data d'inici
Data de tancament
Grup de recerca
Maternal and Fetal Medicine
Descripció
Clinical Researcher, Maternal-Fetal Medicine Unit Assisted reproduction and gynecological endocrinology Unit _20240097
Codi
2024-97
URL Document vinculat
http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0097//2024_0097_001.pdf
Reclutant
Inactiu
Year
2024
Data d'inici
Data de tancament
Grup de recerca
Rheumatology
Descripció
Clinical Research Monitor Rheumatology Research Group_20240098
Codi
2024-98
URL Document vinculat
http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0098//2024_0098_001.pdf
Reclutant
Inactiu

Seguridad, tolerancia y actividad antirretroviral de dasatinib: estudio clínico piloto enpacientes con infección reciente por el VIH-1

Contact
  • Protocol code: DASAHIVCURE
  • EudraCT code: 2021-001288-26
  • Pathology: Certes malalties infeccioses i parasitàries
  • Principal investigator:  Falcó Ferrer, Vicenç
  • Research group:  Malalties infeccioses
  • Service: Infeccioses
  • Phase: Fase IV
  • Recruiting: Open
  • Status: Iniciat

Contact Form

I have read and accept the data protection policy *.

Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.
Purpose: Request for information on VHIR clinical research.
Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.
Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.
Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.
Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information 
The request for information on a research project or clinical trial does not entail inclusion in it.

Estudio de cohortes de fase 2, con un solo grupo, abierto para evaluar la seguridad, la eficacia y lafarmacocinética del tratamiento con esparsentán en pacientes pediátricos con determinadasenfermedades glomerulares proteinúricas (EPPIK).

Contact
  • Protocol code: RTRX-RE021-201
  • EudraCT code: 2021-000621-27
  • Pathology: Malalties del sistema genitourinari
  • Principal investigator:  Ariceta Iraola, Gema
  • Research group:  Fisiopatologia renal
  • Service: Nefrologia Pediàtrica
  • Phase: Fase II
  • Recruiting: Open
  • Status: Open

Contact Form

I have read and accept the data protection policy *.

Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.
Purpose: Request for information on VHIR clinical research.
Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.
Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.
Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.
Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information 
The request for information on a research project or clinical trial does not entail inclusion in it.

ESTUDIO DE FASE III ALEATORIZADO, ABIERTO PARA EVALUAR LA EFICACIA Y SEGURIDAD DE GIREDESTRANT EN COMBINACIÓN CON PHESGO COMPARADO CON PHESGO TRAS TRATAMIENTO DE INDUCCIÓN CON PHESGO + TAXANO EN PACIENTES CON CÁNCER DE MAMA LOCALMENTE AVANZADO O METASTÁSICO HER2 POSITIVO Y RECEPTOR DE ESTRÓGENOS POSITIVO, NO TRATADOS PREVIAMENTE

Contact

Contact Form

I have read and accept the data protection policy *.

Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.
Purpose: Request for information on VHIR clinical research.
Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.
Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.
Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.
Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information 
The request for information on a research project or clinical trial does not entail inclusion in it.

Estudio fase III, multicéntrico, aleatorizado, doble ciego, dosis crónica, de grupos paralelos y controlado con placebo para evaluar la eficacia y seguridad de Tozorakimab en pacientes con enfermedad pulmonar obstructiva crónica (EPOC) sintomática y con historial de exacerbaciones de la EPOC

Contact
  • Protocol code: D9180C00012
  • EudraCT code: No aplica
  • Pathology: Malalties del sistema respiratori
  • Principal investigator:  Barrecheguren Fernández, Miriam
  • Research group:  Pneumologia
  • Service: Pneumologia
  • Phase: Phase III
  • Recruiting: Open
  • Status: Open

Contact Form

I have read and accept the data protection policy *.

Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.
Purpose: Request for information on VHIR clinical research.
Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.
Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.
Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.
Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information 
The request for information on a research project or clinical trial does not entail inclusion in it.